The growing geriatric population and high prevalence of chronic diseases have significantly elevated the needs for better clinical diagnostic services such as point of care technology (POCT) based biosensors. According to the latest market intelligence report by BIS Research titled, ‘Global Biosensors Market- Analysis and Forecast (2018-2027)', the market for biosensors is dominated by electrochemical biosensors. The electrochemical biosensors are leading the market, owing to the high demands for glucose monitoring systems and use of electrochemical biosensors in various such systems, e.g., cardiac marker analysis, infectious diseases, coagulation analysis, and cancer marker analysis. The global market for biosensors is segmented on the basis of region, technology, and applications.
In April 2018, Scientists at the University of Bath developed a biosensor with BlaC E assay system. The BlaC E assay system is a generic platform and can be adapted to a variety of diagnostic tests, if there is a bio recognition element available such as an antibody or a DNA aptamer. The BlaC E assay generates a reliable point of care diagnostic system for cancer that integrates microfluidic and electrochemistry technologies.
In April 2018, researchers from Okinawa Institute of Science and Technology (OIST) Japan, developed a large-scale biosensor using Nano plasmonic material. The Nano plasmonic biosensor resembles a piece of glass, however, its surface is coated with tiny mushrooms like structures called Nano mushrooms. The biosensor can accommodate numerous cells on a single substrate and can monitor cell proliferation. The developed biosensor can detect even eve single molecules.
In February 2018, a team of researchers from National Tsing Hua University and National Cheng Kung University, Taiwan, developed a low-cost, portable, inexpensive medical biosensor. The sensor alert or warns the users about their medical issues ranging from severe heart conditions and cancer. When these biosensors are paired with benchtop point of care instruments used in hospitals and urgent care centres, then these sensors can increase the preventive care measures to be taken for the betterment of patient’s health. The developed biosensor can easily be connected to a smartphone using a Bluetooth and a Wi-Fi.
The market for biosensors is to reach a niche level owing to the presence of numerous company in the market and involved in the manufacturing of biosensors with different technologies to strengthen the growing demands for biosensors. In less turnaround time, biosensors became an integral tool of the healthcare companies and laboratories, which are looking for the point of care testing devices and home diagnostics.
Refences:
